Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Return on Invested Capital (2025)

BridgeBio Pharma (BBIO) has disclosed Return on Invested Capital for 1 consecutive years, with 209.6% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital changed N/A to 209.6% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 209.6% through Dec 2025, changed N/A year-over-year, with the annual reading at 1.06% for FY2025, 53.0% up from the prior year.
  • Return on Invested Capital hit 209.6% in Q4 2025 for BridgeBio Pharma, up from 0.72% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 209.6% in Q4 2025 to a low of 0.39% in Q2 2025.